Koruyucu hekimlikte D vitamininin önemi: Kronik hastalıklardan korunma

D vitamini (D vit) 750 milyon yıldır evrende bulunan en eski hormonlardan biridir. Doğumdan ölüme kadar büyüme, gelişme ve sağlıklı bir iskelet sisteminin sağlanması için gereklidir. D vit eksikliği çocuklarda raşitizm, erişkinlerde ise osteoporoz ve osteomalazi nedenidir. Çok sayıda epidemiyolojik çalışma, güneş ışınının deride D vit üretimiyle iskelet sistemi dışında da etki göstererek prostat kanseri ve meme kanseri gibi bazı kanserler, tip I diyabet, romatoid artrit, multipl skleroz, hipertansiyon vb. çeşitli kronik hastalıkları önlemede önemini desteklemektedir. D vit eksikliğinin önlenmesinde en kolay yol "orta derece" güneş ışını alımı, gereksiniminin güneş ışınıyla karşılanamaması durumunda ise D vit desteğidir. Serum 25(OH)D düzeyinin kontrolu ile D vit eksikliğinin izlemi kronik hastalıklardan korunma için önemlidir.

Anahtar Kelimeler:

Vitamin D, Kronik hastalık, Koruyucu hekimlik, Vitamin D eksikliği

The importance of vitamin D in preventive medicine: Chronical disease prevention

Vitamin D is one of the earliest hormones that exists in the universe since 750 million years. It is necessary from birth to death for growth, development and skeletal health. Vitamin D deficiency causes rickets in childhood, osteoporosis and osteomalacia in adults. There are a number of epidemiologic studies evaluating the preventive role of sunlight exposure anD vitamin D in some chronical diseases. Prostate, breast and colon cancers, type I diabetes, rheumatoid arthritis, multipl sclerosis, hypertension are some of these conditions. The easiest way of prevention from vitamin D deficiency is mild sunlight exposure. Vitamin D supplementation is necessary when the requirement is not met by sunlight exposure. Serum 25(OH)D levels are important in monitoring vitamin D status.

Keywords:

Vitamin D, Chronic Disease, Preventive Medicine, Vitamin D Deficiency,

___

1.Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, anci solar UV. Lancel 1989; 1:1104-5.
2.Holick MF. Vitamin D: a milleniıım perspective. J Celi Bioc-Jıem 2003; 88:296-307.
3.Neshy-O'Dell S, Scaıılon KS, Cogswell MF., Oiffcspic C, Hnllis BW, Looker AC. Hypovitaminosis D prevalence and determinants among African American and white woman of reproductive age: Third National Health and Nutrition Examination Survey, 1988-İ994. Am J Cliıı Nulr 2002; 76:187-92.
4.Holick MF. Vitamin D: importance in Ihe prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Artı J Clin Nutr 200-1; 79:362-71.
5.Holick MF. Vitamin D: the underappreciated D-lighlfull hormone that İs important for skeletal and cellular health. Chit Opin Endokrinol Diabetes 2002; 9:87-98.
6.Kreiter SR, Schwartz RP, Kirkman HN, Charlnn PA, Cali-koğlu AS, Davenport ML. Nutritional rickets in African American breast-fed infants. J Pediutr 2000; 137:153-7.
7.Tanjjpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insuficiency among free-living healty voung adults. Am J Med 2002; 112:659-62.
8.Alagöl F, Shihadeh Y, Boztcpe H, Azizlerli H, Sandalcı Ü. Sunlight exposure anD vitamin D deficiency in Turkish women. J Endocrinol Invest 2000; 23:173- 7.
9.Andıran N, Yordam N, Ozon A. The risk factors lor vitamin D deficiency. Nutrilion 2002; 18:47-50.
10.Pehlivan İ, Hatun Ş, Aydoğan M, Babaoğlu K, Tiirkcr G, Gökalp AS. Maternal serum vilamin D levels in the third trimester of pregnancy. Turk J Med Sei 2002; 32:237-241.
11.Aydın A, llikkan B, Haktan M, ICavunrığlu G. Doğum sırasında annelerdeki D vitamini düzeyleri ve bu düzeylerin mevsimlerle ilişkisi. XXVII. Türk Pediatri Kongresi, 1988 İstanbul. Kongre Kitabı, s. 98.
12.Güzel R, ICozanoğlu E, et al. Vitamin D status and bone mineral density of veiled and unveiled Turkish women. J Womens Health Gend Based Med 2001; 10:765-70.
13.Wortsman J, Matsuoka LY, Chen TC, Lu Z, llolick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72:690-3.
14.Matsuoka LY, ide L, Wortsman .1, MacLaughlin J, Holick MF. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987; 64:1165-8.
15.Holick MF. McCollum Award Lecture, 1994. Vitamin D-new horizons for die 21st century. Am J Clin Nutr 1994; 60:619-30.
16.Clemens TL, Henderson SL, Adams JS, Holick MF. Increased skin piument reduces the capacity of skin to svnthesise vitamin D3. Lancet 1982; 1:74-6.
17.Apperly FL. The relation of solar radiation to cancer mortality in North America. Cancer Res 1941; 1:191.
18.Garland CF, Garland FC, Shaw EK, Comstock GYV, Hel-sink KJ, Gnrham ED. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989; 1:1176-8.
19.Garland FC, Garland CF, Gorliam ED ,Young ,IF. Geographic variation in breast cancer mortality in the United States; a hypothesis involving exposure to soiar radiation. Prev Med 1990; 19:614-22,
20.Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and pre-diagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2003; 11:847-52.
21.Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective eİTect of ultraviolet radiation. Cancer 1992; 70:2861-9.
22.Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002; 94:1867-75.
23.Hernân MA,OIek MJ, Ascherio A, van der mei I. Geographic variation of MS incidence in two prospective studies of US women. Neurology 1999; 51:1711-8.
24.Rustand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 1979; 30:150-6.
25.Feldman D Zhao XY, Krislınan AV. Vitamin D and Prostate Cancer. Endocrinology, January 1, 2000; 141:5-9.
26.MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985; 76:1536-8.
27.Stumpf WE, Sar M, Reid FA, et al. Target cells for 1,25-di-hidroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science, 1979; 206:1188-90,
28.Manolagus SC, Provvcdmi DM, Tsoukas CD. Interactions of 1,25-Dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol 1985;43:113-22.
29.Mathicu C, Adorini L. The coming of age of 1,25- dihidroxy-viıamin D3 analogs as immunomodulatory agents.Trends Mol Med, 2002; 8:174-9.
30.Holick MF. Clinical efficacy of 1, 25-dihydroxyvitamin D3 and its analogues in the treatment of psoriasis. Retinoids 1998; 14:12-7.
31.Kragballc H, Heck HI, Sogaard H. Improvement of psoriasis by a topical Vitamin D3 analogue (MC903) in a double-biind study. Br J Dermatol 1988; 119:223-30.
32.Garland CF. More on preventing skin cancer: sun avoidance will increase incidence of cancers overall. British Med Journal 2003; 327:1228.
33.Autier P, Dore JF. Influence of sun exposures during childhood and during adulthood on melanoma risk. EP1MEL and EORTC Melanoma Cooperative Group. Int J Cancer 1998; 77:533-7.
34.Westerdahl J, Olsson H, Ingvar C. At what age do sunburn episodes play a crucial role for the development of malignant melanoma. Eur J Cancer 1994; 30A: 1647-54.
35.Holick MF. Sunlight dilemma: risk of skin skin canser or bone disease and muscle weakness.Lancet 2001; 357:4-6.
36.Holick MF. Calcium anD vitamin D. Diagnostics and Therapeutics. Clin Lab Med 2000; 20:569-90.
37.Weaver CM, Fleet JC. Vitamin D requirements: current and future. Am J Clin Nutr 2004; 80:1735S-9S.
38.Food and Nutrition Board, I. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. Washington, DC, National Academy Press, 1997.
39.Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health; a review. Altern Med Rev 2005; 10:94-111.
40.Holick MF. Vitamin D. In: Dietary reference intakes for calcium,phosphorus, magnesium, D vit, and fluoride. Washington, DC: Institute of Medicine. National Academy Press, 1997; 250.
41.Heaney RP, DowellMS, Hale CA, Bcndich A. Calcium absorption varies within the reference range from serum 25-hydroxyvitamin D.J Am Coll Nutr 2003; 247:142-6.
42.Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary' intake recommendation for vitamin D. J Nutr 2005; 135:317-22.
43.Hollis BW. The vitamin d epidemic and its health consequences. J Nutr 2005; 135:2739S-48S.
44.Hollis BW, Wagner CL. Vitamin D requirements during lac-tation:high-dose maternal suplementation as therapy to prevent hypovitominosis D for both the mother and the nursing infant. Am J Clin Nutr 2004; 80:1752S-8S.
45.Specker B. Vitamin D requirements during pregnancy. Am J Clin Nutr 2004; 80:1740S-7.